Business we founded
Earlybird Health II Fund
The Health Fund secured 123,4M€ in 2022. The fund focuses on early and later stage opportunities in digital health, medical devices, diagnostics, enabling technologies and biopharma across Europe.
Amyl Therapeutics
Founded in 2021 in Leuven, Belgium, Amyl Therapeutics is a A preclinical-stage biotechnology company pioneering a breakthrough approach to treat rare and severe peripheral protein misfolding diseases and neurodegenerative diseases.
Priothera
Founded in 2020, Priothera is a Dublin based biotech, dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
Handl Therapeutics
Founded in 2019, Handl Therapeutics is based in Leuven, Belgium, and aims to use the power of disease modifying in vivo gene therapy to treat complex neurodegenerative diseases to start addressing significant unmet medical needs in healthcare. The company has been acquired by UCB Pharma in 2020.
NGOs we support
2400 sourires
Their mission is to welcome every child weakened by poverty and violence in a secure environment with care, food and education.